Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945

Cancer

Volumn 98, Issue 6, 2003, Pages 1243-1252

  Fouladi, Maryam ^a,j   Hunt, Daniel L ^a   Pollack, Ian F ^b,c   Dueckers, Gregor ^d   Burger, Peter C ^e   Becker, Laurence E ^f   Yates, Allen J ^g   Gilles, Floyd H ^h   Davis, Richard L ⁱ   Boyett, James M ^a   Finlay, Jonathan L ^d  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g OHIO STATE UNIVERSITY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j CHILDREN S ONCOLOGY GROUP   (United States)

more..

Author keywords

Brain tumors; High grade glioma; Low grade glioma; Pediatrics

Indexed keywords

CISPLATIN; CYTARABINE; DACARBAZINE; HYDROXYUREA; LOMUSTINE; MANNITOL; METHYLPREDNISOLONE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; AGE; ARTICLE; ASTROCYTOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLIOMA; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MULTIMODALITY CANCER THERAPY; NEUROPATHOLOGY; PEDIATRICS; POSTERIOR CRANIAL FOSSA TUMOR; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SPINAL CORD TUMOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; INFANT; INFANT, NEWBORN; LOMUSTINE; MALE; PREDNISOLONE; PROGNOSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 0041414899     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11637     Document Type: Article

References (49)

1. Packer RJ, Lange B, Ater J, et al. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol. 1993;11:850-856.
2. Reddy AT, Packer RJ. Chemotherapy for low-grade gliomas. Childs Nerv Syst. 1999;15:506-513.
3. Packer RJ, Ater J, Allen J, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg. 1997;86:747-754.
4. Gjerris F, Klinken L. Long-term prognosis in children with benign cerebellar astrocytoma. J Neurosurg. 1978;49:179-184.
5. Fisher BJ, Leighton CC, Vujovic O, et al. Results of a policy of surveillance alone after surgical management of pediatric low grade gliomas. Int J Radiar Oncol Biol Phys. 2001;51:704-710.
6. Bataini JP, Delanian S, Ponvert D. Chiasmal gliomas: results of irradiation management in 57 patients and review of literature. Int J Radiat Oncol Biol Phys. 1991;21:615-623.
7. Shaw EG, Daumas-Duport C, Scheithauer BW, et al. Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg. 1989;70:853-861.
8. Packer RJ, Sutton LN, Bilaniuk LT, et al. Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: an update. Ann Neurol. 1988;23:79-85.
9. Rosenstock JG, Evans AE, Schut L. Response to vincristine of recurrent brain tumors in children. J Neurosurg. 1976;45:135-140.
10. Lefkowitz IB, Packer RJ, Sutton LN, et al. Results of the treatment of children with recurrent gliomas with lomustine and vincristine. Cancer. 1988;61:896-902.
11. Friedman HS, Krischer JP, Burger P, et al. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized Phase II study. J Clin Oncol. 1992;10:249-256.
12. Gururangan S, Cavazos C, Ashley D, et al. Phase II study of carboplatin in children with progressive low grade gliomas. J Clin Oncol. 2002;20:2951-2958.
13. Mahoney DH, Cohen ME, Friedman HS, et al. Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group Phase II study. Neuro-Oncol. 2000;2:213-220.
14. Chamberlain MC, Grafe MR. Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide. J Clin Oncol. 1995;13:2072-2076.
15. Pons MA, Finlay JL, Walker RW, et al. Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma. J Neurooncol. 1992;14:151-158.
16. Prados MD, Edwards MS, Rabbitt J, et al. Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol. 1997;32:235-241.
17. Geyer JR, Zeltzer PM, Boyett JM, et al. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. J Clin Oncol. 1994;12:1607-1615.
18. Geyer JR, Finlay JL, Boyett JM, et al. Survival of infants with malignant astrocytomas. A report from the Childrens Cancer Group. Cancer. 1995;75:1045-1050.
19. Finlay JL, Boyett JM, Yates AJ, et al. Randomized Phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol. 1995;13:112-123.
20. Allen JC, Aviner S, Yates AJ, et al. Treatment of high-grade spinal cord astrocytoma of childhood with "8-in-1" chemotherapy and radiotherapy: a pilot study of CCG-945. Children's Cancer Group. J Neurosurg. 1998;88:215-220.
21. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. In: Sobin LH, editor. International histological classification of tumours. Geneva: Springer-Verlag, 1993:11-16.
22. Pollack IF, Finkelstein SD, Woods J, et al. Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med. 2002;346:420-427.
23. Pollack IF, Hamilton RL, Burnham J, et al. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort. Neurosurgery. 2002;50:1238-1244.
24. Pollack IF, Hamilton RL, Finkelstein SD, et al. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood. Cancer Res. 1997;57:304-309.
25. Wu TT, Barnes L, Bakker A, et al. K-ras-2 and p53 genotyping of intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Mod Pathol. 1996;9:199-204.
26. Kim SH, Godfrey T, Jensen RH. Whole genome amplification and molecular genetic analysis of DNA from paraffin-embedded prostate adenocarcinoma tumor tissue. J Urol. 1999;162:1512-1518.
27. Finkelstein SD, Sayegh R, Christensen S, et al. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer. 1993;71:3827-3838.
28. Fults D, Brockmeyer D, Tullous MW, et al. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res. 1992;52:674-679.
29. Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science. 1991;253:49-53.
30. Kaplan ES, Meier P. Non-parametric estimations from incomplete observations. J Am Stat Assoc. 1958;53:457-482.
31. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.
32. Cox DR. Regression models and life tables. J R Stat Soc. 1972;34:187-220.
33. Gajjar A, Sanford RA, Heideman R, et al. Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. J Clin Oncol. 1997;15:2792-2799.
34. Pollack IF, Claassen D, al Shboul Q, et al. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. J Neurosurg. 1995;82:536-547.
35. Tao ML, Barnes PD, Billett AL, et al. Childhood optic chiasm gliomas: radiographic response following radiotherapy and long-term clinical outcome. Int J Radiat Oncol Biol Phys. 1997;39:579-587.
36. Flickinger JC, Torres C, Deutsch M. Management of low-grade gliomas of the optic nerve and chiasm. Cancer. 1988;61:635-642.
37. Horwich A, Bloom HJ. Optic gliomas: radiation therapy and prognosis. Int J Radiat Oncol Biol Phys. 1985;11:1067-1079.
38. Wisoff JH, Abbott R, Epstein F. Surgical management of exophytic chiasmatic-hypothalamic tumors of childhood. J Neurosurg. 1990;73:661-667.
39. Nishio S, Takeshita I, Fujiwara S, et al. Optico-hypothalamic glioma: an analysis of 16 cases. Childs Nerv Syst. 1993;9:334-338.
40. Listernick R, Charrow J, Greenwald M, et al. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr. 1994;125:63-66.
41. Janss AJ, Grundy R, Cnaan A, et al. Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer. 1995;75:1051-1059.
42. Palma L, Guidetti B. Cystic pilocytic astrocytomas of the cerebral hemispheres. Surgical experience with 51 cases and long-term results. J Neurosurg. 1985;62:811-815.
43. Shaw EG, Scheithauer BW, O'Fallon JR. Management of supratentorial low-grade gliomas. Oncology (Huntingt). 1993;7:97-107.
44. Clark GB, Henry JM, McKeever PE. Cerebral pilocytic astrocytoma. Cancer. 1985;56:1128-1133.
45. Garcia DM, Latifi HR, Simpson JR, et al. Astrocytomas of the cerebellum in children. J Neurosurg. 1989;71:661-664.
46. Desai KI, Nadkarni TD, Muzumdar DP, et al. Prognostic factors for cerebellar astrocytomas in children: a study of 102 cases. Pediatr Neurosurg. 2001;35:311-317.
47. Wisoff JH, Sanford R, Holmes E, et al. Impact of surgical resection on low-grade gliomas of childhood: a report from the CCG 9891/POG 9130 low grade astrocytoma study [abstract]. Abstract 73. Tenth International Symposium of Pediatric Neuro-Oncology, June 9-12, 2002; London, England.
48. Nakamura M, Konishi N, Tsunoda S, et al. Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults. Oncology. 2000;58:108-116.
49. Machen SK, Prayson RA. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases. Hum Pathol. 1998;29:1511-1516.